Easing the Disease Burden of Patients with Atopic Dermatitis

Advertise on podcast: Easing the Disease Burden of Patients with Atopic Dermatitis

This podcast has
5 episodes
Language
Date created
2021/11/01
Average duration
9 min.
Release period
1 days

Description

Atopic dermatitis (AD) is a skin condition with substantial direct and indirect effects on patients. Guidelines for the management of AD were published in 2014, and while many of the tenets of basic AD skin care are well established, patients with AD are still not achieving optimal disease control in real-world practice. In this activity, Dr. Jonathan Silverberg reviews the burden of AD and the unmet needs within AD management today. Components of basic skin care from the 2014 guidelines are reviewed, followed by the most recent data supporting approved therapies and newly emerging oral and to

Podcast episodes

Check latest episodes from Easing the Disease Burden of Patients with Atopic Dermatitis podcast


Emerging Therapies: Phase 3 Efficacy & Safety Data
2021/11/01
JAK-STAT inhibitors: oral and topical JAK-STAT inhibitors vs dupilumab IL-13 antagonists IL-31 antagonists
AD Therapies Approved After 2014 AAD Guidelines
2021/11/01
Mechanism of action, indication, efficacy, and safety Dupilumab Crisaborole
Adherence to Evidence-Based Guidelines
2021/11/01
2014 AAD Guidelines Recommendations for topical therapies Recommendations for phototherapy
Components of Basic AD Care
2021/11/01
Role of bathing and moisturizers Role of topical corticosteroids
Unmet Needs in AD Care
2021/11/01
Direct and indirect effects of AD Discordance in disease burden between providers and patients Rates of inadequate disease control

Podcast reviews

Read Easing the Disease Burden of Patients with Atopic Dermatitis podcast reviews


0 out of 5
0 reviews

Podcast sponsorship advertising

Start advertising on Easing the Disease Burden of Patients with Atopic Dermatitis & sponsor relevant audience podcasts


What do you want to promote?

Ad Format

Campaign Budget

Business Details